Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.260
+0.050 (4.13%)
At close: Apr 28, 2026, 4:00 PM EDT
1.246
-0.014 (-1.11%)
Pre-market: Apr 29, 2026, 8:44 AM EDT
Dermata Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 4.84 | 4.31 | 3.97 | 4.02 | 4.4 | |
| Research & Development | 2.93 | 8.2 | 4.07 | 5.65 | 3.46 | |
| Operating Expenses | 7.77 | 12.51 | 8.04 | 9.67 | 7.86 | |
| Operating Income | -7.77 | -12.51 | -8.04 | -9.67 | -7.86 | |
| Interest Expense | - | - | - | - | -0.05 | |
| Interest & Investment Income | 0.22 | 0.23 | 0.25 | 0.06 | - | |
| EBT Excluding Unusual Items | -7.56 | -12.29 | -7.79 | -9.61 | -7.9 | |
| Pretax Income | -7.56 | -12.29 | -7.79 | -9.61 | -7.9 | |
| Net Income | -7.56 | -12.29 | -7.79 | -9.61 | -7.9 | |
| Preferred Dividends & Other Adjustments | - | - | - | - | 2.56 | |
| Net Income to Common | -7.56 | -12.29 | -7.79 | -9.61 | -10.46 | |
| Shares Outstanding (Basic) | 1 | 0 | 0 | - | - | |
| Shares Outstanding (Diluted) | 1 | 0 | 0 | - | - | |
| Shares Change (YoY) | 505.46% | 684.76% | - | - | - | |
| EPS (Basic) | -8.16 | -80.32 | -399.87 | - | - | |
| EPS (Diluted) | -8.16 | -80.32 | -399.87 | - | - | |
| EBITDA | - | - | - | - | -7.86 | |
| D&A For EBITDA | - | - | - | - | 0 | |
| EBIT | -7.77 | -12.51 | -8.04 | -9.67 | -7.86 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.